Published Date: 16 Feb 2023
Many physicians have encountered one or more serious or potentially dangerous patients over the years, and according to Medscape research, patient trust has declined.
Read Full NewsNot all adrenal incidentalomas need the same workup. The Curbsiders break down when to worry, what to test, and why MACS may be behind your patient's hard-to-control metabolic disease.
Dr Maurie Markman examines new registry data on ovarian cancer diagnostic timing, showing how disease biology can complicate the link between early detection and survival.
Dr Andrea Chadwick describes how the shift from tender points to symptom-based criteria has improved fibromyalgia diagnosis, understanding, and patient-centered care.
Dr Anne Peters discusses the expanding use of continuous glucose monitoring in people with diabetes.
Before you freeze a skin lesion, ask yourself whether you really know what it is. Here are four signs you should biopsy instead of freeze.
EyePoint said its experimental drug missed the main goal in a late-stage trial as a few patients lost vision from causes unrelated to the targeted disease, sending its...
The FDA has approved a radioactive agent for use in brain scans to help assess patients for Alzheimer's disease.
1.
ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs
2.
T-DXd Reduces Residual Disease in Early Breast Cancer
3.
Scream, It's Good for You; Release the Cancer Pigeons; Talk of Chemo Rationing
4.
FDA Expands Use of T-DXd in Early HER2+ Breast Cancer
5.
A study suggests that screening for liver cancer is beneficial for patients with cirrhosis.
1.
Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study
2.
Benefits of Neutrophilia: Harnessing the Power of White Blood Cells to Promote Health and Well-Being
3.
Longitudinal Monitoring in Hematologic Care Pathways
4.
Advancing Oncology Careers with Education, Workflow Tools, and Clinical Resources
5.
Critical Care Updates on Hematopoietic Dysfunction During Prolonged Critical Illness
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
2.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
3.
Thromboprophylaxis In Medical Settings
4.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation